3M BacLite MRSA Detector Trial Starts This Week

June 15, 2011

MRSA Bacteria. Photo credit: CDC

HAI Focus recently reported on a lawsuit being brought against U.S. 3M Co. by Ploughshare Innovations, owned by the UK’s Ministry of Defense and the Porton Group, a private equity group. The suit pertains to allegations that 3M failed to commercialize a product for detecting methicillin-resistant staphylococcus aureus (MRSA).

The claims are 3M purposefully mismanaged BacLite testing in order to reduce the competition against a similar 3M-developed product used for identifying the presence of MRSA.

[box style=”rounded”]Related HAI Focus Article: Controversy Stirs Over 3M BacLite MRSA Detector [/box]

Earlier this week (June 13, 2011), 3M responded to the public accusations related to the BacLite product. The following statement was made in 3M’s news release:

“A hallmark of 3M is unwavering commitment to providing effective and reliable products,” says William A. Brewer III, partner at Bickel & Brewer and counsel for 3M. “In the view of the company, BacLite was not commercially viable and it failed to meet certain standards of the marketplace, so the company discontinued its efforts to sell the product.”

Arguments in the case are to begin this week (June 15, 2011) in a U.K. court. The trial is expected to last up to six weeks, with a ruling in late September.

Further Information:

Tita, B. Court Trial to Start Over 3M’s Decision to Kill Superbug Test. The Wall Street Journal. June 15, 2011.

3M Responds to Accusations Regarding BacLite. BusinessWire. June 13, 2011.

 

Leave a Comment

Previous post:

Next post: